Key facts
- St Andrews Pharmaceutical Technology’s last known valuation is $270K (Oct 2021).
- It has raised $180K; the latest was Early Stage VC in Dec 2024.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for St Andrews Pharmaceutical Technology
- ·The full record, as it builds
Funding rounds
No funding rounds for St Andrews Pharmaceutical Technology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About St Andrews Pharmaceutical Technology
The company is currently operating in stealth mode.
- Sector
- Business Products and Services (B2B)
- HQ
- Henley-On-Thames, United Kingdom
- Founded
- 2020
- Employees
- 5
- Ownership
- Privately Held (backing)
St Andrews Pharmaceutical Technology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in St Andrews Pharmaceutical Technology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on St Andrews Pharmaceutical Technology in its N-PORT filings yet. We sweep new filings monthly.